Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-644P (RNA, U6 small nuclear 644, pseudogene) is a **pseudogene** that is derived from the U6 small nuclear RNA gene family[1]. The canonical, functional U6 small nuclear RNA (U6 snRNA) is a non-coding RNA critical for the spliceosome – the molecular machine responsible for pre-mRNA splicing in eukaryotic cells[3][5]. However, pseudogenes like RNU6-644P do not encode functional RNA or protein products and are not known to play direct roles in splicing or other cellular processes. There is no evidence supporting a role for RNU6-644P in disease, as a biomarker, or as a drug target. The sequence is annotated as a non-functional RNA and is not considered a therapeutic target[1]. The U6 small nuclear RNA gene family consists of canonical (functional) genes and many processed pseudogenes scattered throughout the genome. The entry RNU6-644P is one such pseudogene and does **not** code for a functional snRNA, which distinguishes it from *U6 snRNA*, an essential spliceosomal component[1][5]. There are no current reports of pseudogenes from this family acting as disease genes, drug targets, or therapeutic molecules. RNU6-644P is therefore considered an *annotated genomic relic* rather than a molecular target[1]. *is_incorrect* is set to true because RNU6-644P is not a valid therapeutic target, nor a functional molecular entity.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 644, pseudogene (RNU6-644P).